IL1B and Zinc deficiency: Previous studies explained the contribution of zinc deficiency to the increased risk of VOCs in SCD patients because zinc deficiency increases gene expression and production of interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α).